Doctor profile · Federal record
Dr. Peter Hino, M.D.
Dermatology Physician (CMS: Dermatology) · Dallas, TX
- NPI 1053407296
- Accepts Medicare
- MIPS 94.4 / 100 · 2023
- 37 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
8230 Walnut Hill Ln, Suite 500
Dallas, TX 752314482
(214) 739-5821
Credentials & registration
- NPI registered
- October 2006 — 20 yrs on file
- Profile last updated
- February 10, 2022
- Year of graduation
- 1989 — 37 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Texas #H5899
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1053407296. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
6,952
Distinct HCPCS
10
Medicare allowed
$392,522
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 2,832 | 449 | $6 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 1,597 | 1,137 | $86 | |
17000 |
Destruction of precancer skin growth, 1 growth | 883 | 594 | $51 | |
17110 |
Destruction of skin growth, 1-14 growths | 585 | 489 | $109 | |
11102 |
Biopsy of related skin growth, first growth | 467 | 379 | $89 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 126 | 119 | $54 | |
0394T |
High dose rate electronic brachytherapy, external | 114 | 11 | $229 | |
77280 |
Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | 114 | 11 | $264 | |
11103 |
Biopsy of related skin growth, each additional growth | 101 | 70 | $48 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 85 | 85 | $106 |
In context: peer comparison
Among 51 peers in Dallas Dermatology Physician, average services per provider: 218. This provider delivers 32× the peer median.Open Payments
Industry payments received
All-time total
$2,354
Transactions
106
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | 13 | $295.22 | |
| Abbvie INC. | 19 | $293.71 | |
| Genzyme Corporation | 9 | $260.90 | |
| Leo Pharma INC. | 9 | $210.90 | |
| Mayne Pharma Commercial LLC | 7 | $144.72 | |
| Novartis Pharmaceuticals Corporation | 7 | $130.58 | |
| E.R. Squibb & Sons, L.L.C. | 7 | $126.98 | |
| Lilly USA, LLC | 6 | $122.52 | |
| Regeneron Healthcare Solutions, INC. | 4 | $100.62 | |
| Amgen INC. | 4 | $93.84 | |
| Janssen Biotech, INC. | 4 | $84.69 | |
| Galderma Laboratories, L.P. | 5 | $81.66 | |
| Incyte Corporation | 4 | $80.40 | |
| Arcutis Biotherapeutics, INC. | 4 | $74.50 | |
| Dermavant Sciences, INC. | 4 | $64.75 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
580
Patients
260
Total drug cost
$117,458
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Valacyclovir (Valacyclovir Hcl) | Brand | 99 | 35 | $1,942 |
| Clobetasol Propionate | Generic | 96 | 68 | $6,977 |
| Triamcinolone Acetonide | Generic | 73 | 50 | $647 |
| Ketoconazole | Generic | 49 | 28 | $1,078 |
| Doxycycline Hyclate | Generic | 43 | 17 | $882 |
| Halobetasol Propionate | Generic | 35 | 20 | $3,025 |
| Doxycycline Monohydrate | Generic | 34 | 0 | $951 |
| Spironolactone | Generic | 29 | 0 | $529 |
| Tretinoin | Generic | 29 | 0 | $1,697 |
| Desonide | Generic | 18 | 16 | $583 |
Frequently asked questions
What is Dr. Peter Hino's medical specialty?
Dr. Peter Hino practices Dermatology Physician in Dallas, TX.
Where does Dr. Peter Hino practice?
Dr. Peter Hino practices at 8230 Walnut Hill Ln, Dallas, TX 752314482. Office phone: 2147395821.
What is Dr. Peter Hino's NPI?
Dr. Peter Hino's National Provider Identifier (NPI) is 1053407296, issued by NPPES.
Does Dr. Peter Hino accept Medicare assignment?
Yes. Dr. Peter Hino accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Peter Hino commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.